Bitcoin press release: ClinTex Details of their announce CTi Token presaleThis enables participants to access the clinical trials market valued at USD 350 billion / year with a discount of 50% to September 25, 2020.
August 17, 2020, London, United Kingdom – With the current global pandemic around the world, the fiscal ramifications are everywhere, and in industries that were once considered safe havens, impacts that are likely to last a decade are commonplace. From the tech moguls of Silicon Valley to the high-tech manufacturing centers of Europe, it is clear that the world calls for innovation at a time when options are limited.
To this end, London-based ClinTex has the answer to a disempowered financial ecosystem. It seems perfectly prepared to provide a solution to not just medical patients worldwide, but the healthcare industry as a whole, and offer its stakeholders a potentially astounding return on investment through the CTi token presale currently ongoing.
Inefficiencies in the pharmaceutical industry
The value proposition for ClinTex lies in a simple observed fact: for an industry that is considered innovative, the pharmaceutical industry is fraught with inefficiency. At such a remarkable time for global health, these inefficiencies have widespread consequences:
- Big time delays – It can take up to 15 years for a promising drug to reach patients, with untold amounts of heartache and emotional trauma for families and individuals. The CTi platform helps identify problems and avoid savings in the millions.
- High test costs – It costs now over $ 2,500,000,000 Bringing a drug to market, each costing day in clinical trials Revenue erosion of up to $ 8,000,000 per day A new drug is delayed – and these costs are passed on to the patient. CTi will significantly reduce costs and help deliver drugs not only faster, but cheaper to those who need them.
- Bad data quality – With the App for the visualization of clinical data In CTi, fundamental and systemic errors in data can be quickly identified and corrected, resulting in better insights and far better data application. Developments like this lead to a stronger development of the industry in the long term.
- Little to no collaboration – There is currently almost no collaboration between industry players. This problem was compounded by the Covid-19 pandemic. There are many ways to increase efficiency by extracting the intelligence and insights inherent in clinical data around the world – This is perhaps one of the greatest advantages – As the ecosystem gains in value, more partners sign up and the value increases.
COVID-19 & CTi – Return to Rival DeFi?
With the current pandemic and 142 COVID-19 vaccines currently awaiting trial, there has never been a better time to implement CTi in the industry. We are already seeing random research collaboration attempts to find a COVID-19 vaccine and treatments. And with these expenses that may run into the trillions CTi could represent the next generation of innovative wins to follow DeFi at the re-ignition of the crypto wave, which has not been seen since the ICO boom of 2017.
The CTi token pre-sale runs until September 25, 2020and CTi can be bought for a 50% discount from $ 0.05 through Visit this link. CTi worth USD 1 million is available for purchase, which is 10% of the total CTi offering. Leftover tokens will be burned, and the main sale will begin in October 2020, where tokens will be available for $ 0.10.
ClinTex does what all companies strive for in difficult times – innovation. And with a market value of $ 350,000,000,000 per year, The possibilities are endless. Now is the time. Be part of this exciting project and Benefit from discounts on one of the most promising projects in the industry this year Visit the CTi token pre-sale link now.
ClinTex is the source of this content. This press release is for informational purposes only. The information does not constitute investment advice or an offer to invest. The ClinTex token sale is closed to US participants and participants in all countries where ICO / IEOs are illegal. Virtual currency is not legal tender, is not supported by the government, and accounts and balance sheets are not subject to consumer protection. Token sales are only suitable for people with a high risk tolerance. Participate in a token event only with what you can afford to lose.
About Bitcoin PR Buzz: Bitcoin PR Buzz prides itself on meeting crypto press release distribution requirements from blockchain startups over 8 years. Get yours Distribution of Bitcoin press releases today.
This is a press release. Readers should conduct their own due diligence before taking any action related to the advertised company or any of its affiliates or services. Bitcoin.com is not responsible, directly or indirectly, for any damage or loss caused or allegedly caused by or in connection with the use of, or reliance on, any content, goods or services mentioned in the press release.
Photo credit: Shutterstock, Pixabay, Wiki Commons